Disease relevance of Encephalomyelitis, Eastern Equine

• An immunohistochemical (IHC) assay was developed for the detection of eastern equine encephalomyelitis (EEE) virus antigen in formalin-fixed, paraffin-embedded tissues [1].

High impact information on Encephalomyelitis, Eastern Equine

• Mice pretreated with poly(I-C), a nonspecific IFN inducer, exhibited dose-dependent protection against fatal eastern equine encephalitis, further evidence that IFN is important in controlling disease [2].
• The 26S mRNA and most of the nsP4 encoding regions of the eastern equine encephalomyelitis (EEE) viral genome have been cloned [3].
• Differential reactivity of immune sera from human vaccinees with field strains of eastern equine encephalitis virus [4].
• An Eastern equine encephalitis (EEE) outbreak in 1989 led to nine human and 196 equine cases, chiefly in coastal Atlantic and Gulf Coast counties [5].
• Naturally occurring eastern equine encephalitis in a Hampshire wether [6].

Chemical compound and disease context of Encephalomyelitis, Eastern Equine

• Impact of naled on the mosquito vectors of eastern equine encephalitis virus [7].
• Adult female density, parity status, and wing length were determined weekly for a population of Coquillettidia perturbans in an area enzootic for eastern equine encephalitis virus in central Ohio. Samples were collected in CO2-baited CDC miniature light traps from the first week in June through the 2nd week of September 1992 [8].

Gene context of Encephalomyelitis, Eastern Equine

• A few sera were HI-positive with Mucambo, eastern equine encephalitis (EEE), Oriboca, Restan, Manzanilla, Guama, Bimiti, and Catu [9].
• Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes [10].

References